Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Substance Withdrawal Syndrome: full-pipeline trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Substance Withdrawal Syndrome: 4 US clinical trials tracked, none currently recruiting.
Substance Withdrawal Syndrome is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Duquesne University, running 1 of these trials.
Enrollment posture brief
Registry condition substance-withdrawal-syndrome
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Substance Withdrawal Syndrome has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Substance Withdrawal Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Substance Withdrawal Syndrome is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
University of California, Los Angeles
NCT00032968
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
University of Vermont
NCT02825459
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program
Duquesne University
NCT02431728
Effect of Ondansetron for Withdrawal Symptoms
Stanford University
NCT00695864
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Substance Withdrawal Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Substance Withdrawal Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Substance Withdrawal Syndrome page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Substance Withdrawal Syndrome trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Duquesne University sponsors the most Substance Withdrawal Syndrome trials on record, review their full trial history before evaluating a specific study. See Duquesne University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Substance Withdrawal Syndrome condition card totals 4 registered trials; most-linked intervention Abstinence from e-cigarettes; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.